Packager limits intra-facility travel to address ‘critical out-of-cold-storage time’

By Maggie Lynch

- Last updated on GMT

(Image: Getty/nordroden)
(Image: Getty/nordroden)

Related tags Cold chain Packaging Packaging and labeling Manufacturing

Contract packaging provider Reed-Lane adds dedicated room for vial and ampule kitting to its cold chain capabilities to limit intra-facility travel and product excursion as a means of security.

The New Jersey-based company will add the dedicated room adjacent to its existing cold chain infrastructure. It will include space for the labeling of vials and ampules and the kitting of them with other components.

Patricia Elvin, president of Reed-Lane, said in a statement that the dedicated environment for vial and ampoule kitting was developed in an aim to demonstrate the company’s commitment to growing its cold chain capabilities, in response to demand from biopharma and pharma manufacturers.

With the addition of new vial and ampule kitting room, Reed-Lane will provide a secure cold chain through the storage of handling and transporting temperature-sensitive drugs without extraneous travel.

Joe Luke, VP of sales and marketing for Reed-Lane, told us, “Because the kitting room is dedicated only for ampoule vial and kitting, and is located next to our cold chain storage room, this allows products to be out of cold storage for just 2-3 hours to be packaged – and then brought right back to cold storage.”

“Therefore, logistically it is ideal to have the cold storage room adjacent to the kitting room. In other facilities, the rooms may be further apart and require intra-facility travel, which sounds trivial but can add critical out-of-cold-storage time to the process,”​ he added.

Once products are kitted they will be transported to the company’s serialization suite capable of handling serialization from unit-level coding to full pallet aggregation. Luke explained that for cold storage pharmaceuticals, products that come from cold storage for labeling and kitting go through a process in which serialization that is now incorporated with the site’s machine configuration.

With this setup, the cold chain products are then able to be quickly returned to cold storage until shipment.

Related news

Related products

show more

Connectivity & Integration in Biomanufacturing

Connectivity & Integration in Biomanufacturing

Wheeler Bio | 17-Nov-2022 | Technical / White Paper

As the Pharma 4.0 initiative sets a new industry paradigm, more biomanufacturing companies are asking how they can design and build facilities that apply...

Scalability, Quality, and Speed with Transposons

Scalability, Quality, and Speed with Transposons

Wheeler Bio | 20-Oct-2022 | Technical / White Paper

To solve for the significant bottlenecks often presented by conventional cell line development processes, this article discusses how Wheeler Bio is leveraging...

Accelerating Time to IND with Pharma 4.0

Accelerating Time to IND with Pharma 4.0

Wheeler Bio | 22-Sep-2022 | Technical / White Paper

The future of the biopharmaceutical industry hinges on its adoption of 21st-century digital tools and automation.

Follow us


View more